Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lexicon Pharmaceuticals
Pharma
Lexicon preps FDA resubmission for diabetes hopeful Zynquista
The company hopes its long and bumpy five-year journey will soon see an end with an FDA approval.
Zoey Becker
Mar 12, 2024 7:15am
Lexicon poaches BMS' Tom Garner as new commercial lead
Oct 10, 2023 9:45am
Lexicon finally scores FDA nod for heart failure drug Inpefa
May 30, 2023 9:55am
In pursuit of approval, Lexicon undaunted against unwavering FDA
Dec 1, 2022 8:55am
ACC: Lexicon's sotagliflozin can cut stroke, heart attack
Apr 2, 2022 3:37pm
Lexicon pulls FDA submission for sotagliflozin to fix issue
Feb 28, 2022 10:38am